Drugs / Non-adjuvanted A(H1N1)v influenza vaccine
last change Dec 2011 re-read 3 minutes ago

Non-adjuvanted A(H1N1)v influenza vaccine

Vaccine

Developed for
influenza
Investigated by
French National Institute of Health and Medical Research · MCM Vaccines B.V.

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01024400 Nov 2009 → Jan 2010 influenza French National Institute of Health and Medical Research Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Non-adjuvanted A(H1N1)v influenza vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01024400 ↗
Known as nonadjuvanted H1N1 vaccine “INTERVENTION: An intramuscular dose of a nonadjuvanted H1N1 vaccine that contained 15 mcg of hemagglutinin.” PMID 22147712 ↗ Dec 2011
Modality Vaccine “nonadjuvanted H1N1 vaccine” PMID 22147712 ↗ Dec 2011
Route Intramuscular “An intramuscular dose of a nonadjuvanted H1N1 vaccine that contained 15 mcg of hemagglutinin.” PMID 22147712 ↗ Dec 2011